How to handle an industry in disruption: Intervene or laissez-faire?

See allHide authors and affiliations

Science Translational Medicine  06 May 2015:
Vol. 7, Issue 286, pp. 286ps12
DOI: 10.1126/scitranslmed.aaa3679

You are currently viewing the abstract.

View Full Text


An analysis of four regions in four countries suggests that the best way to mitigate disruption of the pharmaceutical industry is not to ignore or stem it but to sponsor initiatives that keep scientists engaged.

View Full Text